NP213 (Novexatin(®)): A unique therapy candidate for onychomycosis with a differentiated safety and efficacy profile

por Mercer, Derry K, Robertson, Jennifer C, Miller, Lorna, Stewart, Colin S, O'Neil, Deborah A
Publicado 2020